Ibutilide infusion increased atrial flutter cycle length from 260 to 295 ms (P<0.0003) and effective refractory periods from 149 to 208 ms (P<0.001), abolishing a fully excitable gap.
Does ibutilide alter the electrophysiological properties of the right atrium in patients with typical atrial flutter?
Ibutilide prolongs atrial flutter cycle length and effective refractory periods, abolishing the fully excitable gap and facilitating pace termination.
Absolute Event Rate: 295% vs 260%
p-value: p=<0.0003
BACKGROUND: The efficacy of ibutilide in conversion of atrial fibrillation and flutter (AFL) has been demonstrated. However, its electrophysiological effects on human atria have not been fully studied. METHODS AND RESULTS: Twelve patients with typical AFL were studied. Electrograms were recorded from the anterolateral right atrium, His bundle position, and coronary sinus. During AFL, we measured the conduction time, CTi, through the isthmus between the tricuspid annulus and eustachian ridge and the conduction time, CTni, through the remainder of the right atrium. Resetting response curves and atrial effective refractory periods were determined with single extrastimuli delivered in the tricuspid annulus-eustachian ridge isthmus. After infusion of ibutilide (2 mg over 15 minutes), AFL cycle length (CL) increased from 260+/-30 to 295+/-39 ms (P<0.0003) because of an increase in either CTi, CTni, or both. Effective refractory periods increased from 149+/-16 to 208+/-26 ms (P<0.001). AFL CL variability increased, with a rightward shift of the resetting response curves and loss of full excitability. In 8 patients, AFL was terminated by atrial overdrive pacing after ibutilide at CLs equal to or longer than those that were not effective at baseline, which was caused by orthodromic block in the tricuspid annulus-eustachian ridge isthmus or was associated with development of transient rapid rhythms around newly formed sites of intra-atrial conduction block. CONCLUSIONS: Ibutilide causes prolongation of AFL CL and increased CL variability by abolishment of a fully excitable gap. Ibutilide may facilitate pace termination of AFL by development of new short-lived reentry around functional blocks.
Cheng et al. (Tue,) conducted a other in Typical atrial flutter (n=12). Ibutilide vs. Baseline was evaluated on Atrial flutter cycle length (p=<0.0003). Ibutilide infusion increased atrial flutter cycle length from 260 to 295 ms (P<0.0003) and effective refractory periods from 149 to 208 ms (P<0.001), abolishing a fully excitable gap.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: